ALPS ‘SBIO’ ETF: Trial Progress Meets Investing Success

Clinical trials are of the utmost importance to biotechnology investors, but not all exchange traded funds adequately address the phenomenon. The ALPS Medical Breakthroughs ETF (SBIO) takes a different approach. SBIO focuses on small- and mid-cap companies that have one or more drugs in either...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.